Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
about
Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strainsMolecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureusNationwide molecular epidemiology of methicillin-resistant Staphylococcus aureus responsible for horse infections in France.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections.Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.Chromosomal islands of Streptococcus pyogenes and related streptococci: molecular switches for survival and virulence.The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus.Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability.From the wound to the bench: exoproteome interplay between wound-colonizing Staphylococcus aureus strains and co-existing bacteria.Prevalence and Genetic Basis of Antimicrobial Resistance in Non-aureus Staphylococci Isolated from Canadian Dairy Herds.
P2860
Q28486717-F9D2C6DC-3491-4042-B436-D5BEB353DEA1Q30416768-9DFF82D4-C0ED-42DD-BDC8-EC37DD1AF6ABQ33634695-457AFE7D-24D7-4C8C-8831-A04D5EFF4FD1Q34297656-1AD78BD5-F80D-401C-B7FD-D2C06EFAB6BFQ35598346-56581856-922B-4971-98F3-DEA4CBE55A1AQ37286906-662060CC-BB78-4FA5-93ED-070FC4EFC854Q38243813-B47089D1-D671-46EE-8B09-D68490AAFD17Q38898519-FD586A54-0B28-467D-AF82-99C7E75C27CAQ41773256-A66FC1E6-935F-48A7-8068-21D59DF5CEF5Q41991607-197B4AA6-925A-4514-A423-830463BD617CQ46242819-48EBE53A-1517-4B6F-9B35-094883430CCCQ50351287-23EA50AF-C314-4C89-80EA-B82165BCD77B
P2860
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
@ast
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
@en
type
label
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
@ast
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
@en
prefLabel
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
@ast
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
@en
P2093
P2860
P1476
Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
@en
P2093
Anne-Laure Prunier
Hiep N'Guyen Trong
Roland Leclercq
P2860
P304
P356
10.1128/AAC.49.5.2098-2101.2005
P407
P577
2005-05-01T00:00:00Z